The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals.

Here's where Dr. David Eifrig says to move your money immediately.

EIGR Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.22%

Insider Buying (Last 12 Months): $44,170.20

Insider Selling (Last 12 Months): $0.00

Eiger BioPharmaceuticals Insider Trading History Chart

Eiger BioPharmaceuticals Share Price & Price History

^$0.00

+0.30 (1.20%)

As of 04/10/2024 05:00 PM ET

Days: 30 | 90 | 365

Move Your Money Before May 1

From Stansberry Research | Ad

Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens?

Click here to get the full story before May 1.

Eiger BioPharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/2/2023	Richard A Kayne	Major Shareholder	Buy	779	$9.00	$7,011.00	179,174
10/31/2023	Richard A Kayne	Major Shareholder	Buy	5,161	$7.20	$37,159.20	175,060
3/17/2023	Eldon C. Mayer, III	VP	Sell	146	$32.10	$4,686.60	1,869
1/23/2023	Thomas John Dietz	Director	Buy	1,666	$42.90	$71,471.40	1,666
12/22/2022	Thomas John Dietz	Director	Sell	750	$35.10	$26,325.00	700
8/16/2022	David Apelian	Director	Sell	166	$294.30	$48,853.80	366
3/14/2022	Eldon C. Mayer, III	VP	Sell	55	$168.00	$9,240.00
3/14/2022	Sriram Ryali	CFO	Sell	75	$168.00	$12,600.00
1/7/2022	Eldon C. Mayer, III	VP	Sell	52	$148.50	$7,722.00

Move Your Money Before May 22

From Stansberry Research | Ad

Here's where Dr. David Eifrig says to move your money immediately.

SEC Filings (Institutional Ownership Changes) for Eiger BioPharmaceuticals (NASDAQ:EIGR)

62.46% of Eiger BioPharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Eiger BioPharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/14/2023	683 Capital Management LLC	2,650,000	$0.81M	0.1%	-29.3%	5.982%
8/14/2023	683 Capital Management LLC	3,750,000	$2.64M	0.2%	-5.1%	8.465%
8/8/2023	Sequoia Financial Advisors LLC	63,000	$44K	0.0%	N/A	0.142%
8/7/2023	Acadian Asset Management LLC	206,113	$0.15M	0.0%	-27.0%	0.465%
8/2/2023	Sigma Planning Corp	101,500	$71K	0.0%	-50.3%	0.229%
7/20/2023	DAVENPORT & Co LLC	208,701	$0.15M	0.0%	-9.9%	0.471%
5/12/2023	Forefront Analytics LLC	51,679	$46K	0.0%	+317.5%	0.117%
5/10/2023	Simplify Asset Management Inc.	1,099,653	$0.99M	0.1%	N/A	2.483%
5/8/2023	Sigma Planning Corp	204,350	$0.18M	0.0%	+75.7%	0.461%
2/14/2023	683 Capital Management LLC	3,115,000	$3.68M	0.3%	-28.1%	7.068%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	37,881	$45K	0.0%	-22.2%	0.086%
2/9/2023	Tocqueville Asset Management L.P.	51,075	$60K	0.0%	-28.6%	0.116%
1/24/2023	Sigma Planning Corp	116,300	$0.14M	0.0%	+81.9%	0.264%
1/20/2023	DAVENPORT & Co LLC	235,701	$0.28M	0.0%	-6.7%	0.535%
1/12/2023	Assenagon Asset Management S.A.	632,749	$0.75M	0.0%	+3.0%	1.436%
11/17/2022	Telemetry Investments L.L.C.	178,500	$1.34M	1.7%	-35.8%	0.405%
11/15/2022	Knoll Capital Management LLC	585,966	$0.59M	0.3%	-15.6%	1.330%
11/15/2022	Carlson Capital L P	55,000	$0.41M	0.0%	-15.4%	0.125%
11/14/2022	Annandale Capital LLC	30,000	$0.23M	0.1%	N/A	0.068%
11/14/2022	683 Capital Management LLC	4,329,751	$32.60M	2.5%	+12.0%	9.824%
11/14/2022	UBS Oconnor LLC	222,041	$1.67M	0.0%	-27.0%	0.504%
11/14/2022	MetLife Investment Management LLC	20,652	$0.16M	0.0%	+44.0%	0.047%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	48,668	$0.37M	0.0%	+238.6%	0.110%
11/8/2022	Curi Wealth Management LLC	45,000	$0.34M	0.1%	N/A	0.102%
11/8/2022	New York State Common Retirement Fund	29,081	$0.22M	0.0%	+91.9%	0.066%
11/7/2022	Fox Run Management L.L.C.	12,349	$93K	0.0%	N/A	0.028%
11/4/2022	Prudential Financial Inc.	197,795	$1.49M	0.0%	+222.4%	0.450%
11/3/2022	ACT Capital Management LLC	235,000	$1.77M	2.4%	-6.0%	0.534%
10/27/2022	Assenagon Asset Management S.A.	614,361	$4.63M	0.0%	-3.6%	1.397%
10/11/2022	DAVENPORT & Co LLC	252,601	$1.90M	0.0%	+12.3%	0.574%
8/11/2022	Sigma Planning Corp	63,700	$0.40M	0.0%	+2.2%	0.145%
8/11/2022	Knott David M Jr	409,292	$2.58M	1.1%	+5.1%	0.931%
8/5/2022	Connor Clark & Lunn Investment Management Ltd.	14,374	$91K	0.0%	-37.9%	0.033%
8/4/2022	Towerview LLC	25,000	$0.16M	0.1%	-50.0%	0.058%
7/27/2022	Assenagon Asset Management S.A.	637,133	$4.01M	0.0%	+4.3%	1.474%
7/26/2022	Mirae Asset Global Investments Co. Ltd.	10,054	$63K	0.0%	N/A	0.023%
7/20/2022	Clear Harbor Asset Management LLC	20,503	$0.13M	0.0%	N/A	0.047%
7/18/2022	DAVENPORT & Co LLC	224,901	$1.42M	0.0%	-2.0%	0.520%
6/30/2022	Amalgamated Bank	3,871	$32K	0.0%	N/A	0.009%
5/13/2022	Parkman Healthcare Partners LLC	50,000	$0.42M	0.1%	N/A	0.116%
5/13/2022	EAM Investors LLC	126,696	$1.05M	0.2%	N/A	0.293%
5/12/2022	Connor Clark & Lunn Investment Management Ltd.	23,146	$0.19M	0.0%	N/A	0.067%
5/11/2022	ACT Capital Management LLC	250,000	$2.08M	2.2%	+57.7%	0.722%
5/11/2022	Skandinaviska Enskilda Banken AB publ	101,231	$0.84M	0.0%	N/A	0.292%
5/5/2022	Towerview LLC	50,000	$0.42M	0.2%	-63.0%	0.144%
5/4/2022	Advisor Group Holdings Inc.	113,850	$0.94M	0.0%	+15.4%	0.329%
5/2/2022	DAVENPORT & Co LLC	229,601	$1.91M	0.0%	-2.8%	0.663%
4/27/2022	Dupont Capital Management Corp	37,393	$0.31M	0.0%	+63.3%	0.108%
4/25/2022	Assenagon Asset Management S.A.	610,946	$5.07M	0.0%	+173.3%	1.764%
4/21/2022	Trellus Management Company LLC	300,000	$2.49M	1.4%	+4.7%	0.866%
4/21/2022	P.A.W. Capital Corp	540,000	$4.48M	4.7%	+8.0%	1.559%
4/20/2022	Belvedere Trading LLC	21,460	$0.14M	0.0%	N/A	0.062%
4/13/2022	Interwest Venture Management Co.	560,990	$4.66M	1.8%	-26.7%	1.619%
4/11/2022	Sanders Morris Harris LLC	13,800	$0.12M	0.0%	N/A	0.040%
2/15/2022	683 Capital Management LLC	3,300,000	$17.13M	0.6%	+3.9%	9.713%
2/14/2022	Altium Capital Management LP	261,000	$1.36M	0.4%	+32.2%	0.768%
2/14/2022	GSA Capital Partners LLP	184,980	$0.96M	0.1%	+24.8%	0.544%
2/10/2022	Panagora Asset Management Inc.	59,531	$0.31M	0.0%	+162.7%	0.175%
2/10/2022	P.A.W. Capital Corp	500,000	$2.60M	2.4%	+25.0%	1.472%
2/9/2022	Dimensional Fund Advisors LP	285,638	$1.48M	0.0%	+35.4%	0.841%
2/8/2022	Northern Trust Corp	335,210	$1.74M	0.0%	-2.0%	0.987%
2/1/2022	Assenagon Asset Management S.A.	223,525	$1.16M	0.0%	N/A	0.658%
1/31/2022	Dupont Capital Management Corp	22,894	$0.12M	0.0%	-28.5%	0.067%
1/31/2022	Trellus Management Company LLC	286,459	$1.49M	1.0%	+17.4%	0.843%
1/28/2022	Allspring Global Investments Holdings LLC	14,005	$72K	0.0%	N/A	0.041%
1/21/2022	Russell Investments Group Ltd.	320,753	$1.66M	0.0%	+127.8%	0.944%
11/16/2021	Two Sigma Advisers LP	110,739	$0.74M	0.0%	-37.0%	0.326%
11/16/2021	Telemetry Investments L.L.C.	195,121	$1.30M	1.8%	+25.4%	0.574%
11/16/2021	Caxton Corp	140,622	$0.94M	0.8%	+1.4%	0.414%
11/15/2021	683 Capital Management LLC	3,175,000	$21.21M	0.8%	+7.6%	9.345%
11/15/2021	Tocqueville Asset Management L.P.	58,325	$0.39M	0.0%	+12.3%	0.172%
11/15/2021	Dimensional Fund Advisors LP	210,933	$1.41M	0.0%	+12.4%	0.621%
11/15/2021	GSA Capital Partners LLP	148,185	$0.99M	0.1%	+85.4%	0.436%
11/15/2021	Knott David M	312,492	$2.09M	0.8%	+9.1%	0.920%
11/12/2021	Renaissance Technologies LLC	132,884	$0.89M	0.0%	+295.2%	0.391%
11/12/2021	Apis Capital Advisors LLC	40,000	$0.27M	0.3%	N/A	0.118%
11/12/2021	Geode Capital Management LLC	607,793	$4.06M	0.0%	+1.6%	1.789%
11/12/2021	Wolverine Trading LLC	11,253	$76K	0.0%	N/A	0.033%
11/10/2021	Goldman Sachs Group Inc.	380,975	$2.55M	0.0%	-8.3%	1.122%
11/10/2021	Panagora Asset Management Inc.	22,664	$0.15M	0.0%	+3,257.6%	0.067%
11/10/2021	Citigroup Inc.	9,921	$66K	0.0%	+26.9%	0.029%
11/9/2021	Barclays PLC	13,089	$87K	0.0%	+57.6%	0.039%
11/9/2021	BlackRock Inc.	2,474,139	$16.53M	0.0%	-0.1%	7.281%
11/8/2021	Russell Investments Group Ltd.	140,793	$0.94M	0.0%	+28.4%	0.415%
11/5/2021	Advisor Group Holdings Inc.	99,750	$0.67M	0.0%	+11.1%	0.294%
11/3/2021	Dupont Capital Management Corp	32,022	$0.21M	0.0%	N/A	0.094%
11/2/2021	New York State Common Retirement Fund	15,268	$0.10M	0.0%	-43.2%	0.045%
11/1/2021	SG Americas Securities LLC	22,649	$0.15M	0.0%	N/A	0.067%
10/28/2021	Sigma Planning Corp	61,150	$0.41M	0.0%	+283.4%	0.180%
8/17/2021	Weiss Multi Strategy Advisers LLC	207,000	$1.76M	0.0%	+3.5%	0.610%
8/17/2021	Zeke Capital Advisors LLC	35,500	$0.30M	0.0%	+7.6%	0.105%
8/17/2021	683 Capital Management LLC	2,950,000	$25.14M	0.9%	+9.9%	8.689%
8/17/2021	Boothbay Fund Management LLC	27,999	$0.24M	0.0%	+63.8%	0.082%
8/17/2021	Bridgeway Capital Management LLC	128,900	$1.10M	0.0%	N/A	0.380%
8/17/2021	Caxton Corp	138,626	$1.18M	0.8%	+47.3%	0.408%
8/16/2021	California State Teachers Retirement System	44,214	$0.38M	0.0%	-4.4%	0.130%
8/16/2021	Charles Schwab Investment Management Inc.	83,031	$0.71M	0.0%	+7.9%	0.245%
8/16/2021	Telemetry Investments L.L.C.	155,573	$1.33M	1.8%	+3.4%	0.458%
8/16/2021	State Street Corp	541,596	$4.61M	0.0%	+6.1%	1.595%
8/16/2021	Nuveen Asset Management LLC	129,754	$1.11M	0.0%	+15.9%	0.382%

Data available starting January 2016

Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to treat hepatitis delta virus infection. The company's product candidate also include Lambda, which targets type III interferon receptors that has completed Phase II clinical trials; Lonafarnib for the treatment of progeria and progeroid laminopathies; and Avexitide for the treatment of congenital hyperinsulinism, as well as has completed Phase II clinical trials to treat post-bariatric hypoglycemia. Eiger BioPharmaceuticals, Inc. was founded in 2008 and is headquartered in Palo Alto, California.

Today's Range

Now: N/A

50 Day Range

MA: $4.85

$1.30

$7.17

52 Week Range

Now: N/A

Volume

137,800 shs

Average Volume

103,866 shs

Market Capitalization

$2.55 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.83

Who are the company insiders with the largest holdings of Eiger BioPharmaceuticals?: Eiger BioPharmaceuticals' top insider shareholders include:
Richard A Kayne (Major Shareholder)
Eldon C Mayer III (VP)
Thomas John Dietz (Director)
David Apelian (Director)
Learn More about top insider investors at Eiger BioPharmaceuticals.

Move Your Money Before May 22

From Stansberry Research | Ad

Here's where Dr. David Eifrig says to move your money immediately.

EIGR Insider Trading

Eiger BioPharmaceuticals Insider Trading History Chart

Eiger BioPharmaceuticals Share Price & Price History

Eiger BioPharmaceuticals Insider Trading History

SEC Filings (Institutional Ownership Changes) for Eiger BioPharmaceuticals (NASDAQ:EIGR)

Institutional Buying and Selling by Quarter

Eiger BioPharmaceuticals Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Eiger BioPharmaceuticals?